Activated Clotting Time During Unfractionated Heparin-Supported Coronary Intervention Is Access Site the New Piece of the Puzzle?

被引：1
作者：
Valgimigli, Marco [1 ]
Gargiulo, Giuseppe [1 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Dept Cardiol, Bern, Switzerland
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2018年 / 11卷 / 11期
关键词：
activated clotted time (ACT); clinical outcomes; heparin; percutaneous coronary intervention (PCI); radial access; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; ANTICOAGULATION; IMPACT; THERAPY; COMPLICATIONS; TRIALS;
D O I：
10.1016/j.jcin.2018.02.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1046 / 1049
页数：4
相关论文
共 18 条
  • [1] Relation between the degree of procedural anticoagulation and complications after coronary stent implantation
    Ashby, DT
    Dangas, G
    Aymong, EA
    Farkouh, ME
    Mehran, R
    Lansky, AJ
    Moses, JW
    Leon, MB
    Stone, GW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (03) : 319 - 322
  • [2] Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy
    Bertrand, Olivier F.
    Rodes-Cabau, Josep
    Rinfret, Stephane
    Larose, Eric
    Bagur, Rodrigo
    Proulx, Guy
    Gleeton, Onil
    Costerousse, Olivier
    De Larochelliere, Robert
    Roy, Louis
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (09) : 1235 - 1240
  • [3] THE USE OF ACTIVATED CLOTTING TIMES TO MONITOR HEPARIN-THERAPY DURING AND AFTER INTERVENTIONAL PROCEDURES
    BOWERS, J
    FERGUSON, JJ
    [J]. CLINICAL CARDIOLOGY, 1994, 17 (07) : 357 - 361
  • [4] Relationship between activated clotting time and ischemic or hemorrhagic complications - Analysis of 4 recent randomized clinical trials of percutaneous coronary intervention
    Brener, SJ
    Moliterno, DJ
    Lincoff, AM
    Steinhubl, SR
    Wolski, KE
    Topol, EJ
    [J]. CIRCULATION, 2004, 110 (08) : 994 - 998
  • [5] Chew DP, 2001, CIRCULATION, V103, P961
  • [6] Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non-ST-Segment-Elevation Myocardial Infarction Insights From the FUTURA/OASIS-8 Trial
    Ducrocq, Gregory
    Jolly, Sanjit
    Mehta, Shamir R.
    Rao, Sunil V.
    Patel, Tejas
    Moreno, Raul
    Gao, Peggy
    Steg, Philippe Gabriel
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (04)
  • [7] RELATION BETWEEN PROCEDURAL ACTIVATED COAGULATION TIME AND OUTCOME AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    FERGUSON, JJ
    DOUGHERTY, KG
    GAOS, CM
    BUSH, HS
    MARSH, KC
    LEACHMAN, DR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) : 1061 - 1065
  • [8] Developing drugs for use before, during and soon after percutaneous coronary intervention
    Gargiulo, Giuseppe
    Moschovitis, Aris
    Windecker, Stephan
    Valgimigli, Marco
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (06) : 803 - 818
  • [9] Association Between Maximal Activated Clotting Time and Major Bleeding Complications During Transradial and Transfemoral Percutaneous Coronary Intervention
    Louis, David W.
    Kennedy, Kevin
    Lima, Fabio V.
    Pancholy, Samir B.
    Abbott, J. Dawn
    Gordon, Paul
    Aronow, Herbert D.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (11) : 1036 - 1045
  • [10] Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial
    Montalescot, Gilles
    Cohen, Marc
    Salette, Genevieve
    Desmet, Walter J.
    Macaya, Carlos
    Aylward, Philip E. G.
    Steg, Ph. Gabriel
    White, Harvey D.
    Gallo, Richard
    Steinhubl, Steven R.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (04) : 462 - 471
12